Regeneron Pharmaceuticals (REGN) Ownership - Who owns Regeneron Pharmaceuticals?

Industry: @Biotechnology
10 days until earnings call

Profile

Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
117.19B
P/E Ratio
31.40
Total Cash
10.52B
Projected Growth
1.76
Total Debt
2.7B
Revenue
13.1B
Risk (Beta)
0.48
Dividend Yield
N/A
Total Cash/Share
95.47
Total Debt/Equity
24.02
Revenue/Share
114.94 USD as % of share price

Fundamentals

REGN
Capitalization
117B
P/E Ratio
31.40
Risk (Beta)
0.48
Dividend Yield
N/A
Total Cash
10.5B
Total Cash/Share
95.47
Total Debt
2.7B
Total Debt/Equity
24.02
Projected Growth (PEG Ratio)
1.76
Revenue/Share (as % of the share price)
114.94%
Revenue
13.1B
ROE
N/A
Book Value
27B
P/B Ratio
4.34
Cash Flow
N/A
Earnings
36.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
5.27
Current Revenue Per Employee
233829.00
Dividends Per Share - Security
N/A
EBITDA
4.55B
Float
N/A
Float - Current
N/A
Gross Income Margin
86.21
Revenue To Assets
11.98
Shares Held By Institutions
233B
Shares Outstanding - Current
110M
Total Liabilities
7.38B
Total Volume MTD
N/A
Value
-1
Gain YTD
21.099
View a ticker or compare two or three
REGN
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com